Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.
The ACCC got what it wanted when IVF providers Virtus Health and Healius terminated a proposed $45 million merger, but it wasn’t a win, a judge has said in mostly denying the regulator’s bid to recover the costs of its court challenge to the deal.
A judge has found Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.
An appeals court challenge by a group of small businesses seeking coverage under business interruption insurance policies for losses flowing from COVID-19 restrictions has largely failed.
The former CEO of Blue Star Helium is challenging a ruling that slugged him with a $40,000 penalty and a four-year ban for failing to disclose to shareholders the identify of the buyer behind a botched sale of Texas oil assets.
Law firm DLA Piper has picked up a pre-eminent property partner from Moray & Agnew, who advised on the $175 million joint venture between GPT and QuadReal Property Ground to acquire logistics developments on Australia’s eastern seaboard. On Monday, Sallie Bowtell was appointed to DLA Piper’s real estate practice in Melbourne, where the team’s head,…
Labour on-hire and recruitment company CoreStaff has settled a class action alleging it lured workers to Australia from Papua New Guinea with the promise of long-term work, only to terminate their employment agreements less than three years after they relocated.
Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its “inherently implausible” opposition to the patent.
IVF company Virtus Health has withdrawn its offer to acquire rival Adora Fertility from Healius, citing the competition regulator’s opposition to the takeover.
The former CEO and chairman of Antares Energy has been banned from managing corporations for four years and hit with a $40,000 penalty for failing to disclose to the market the buyer behind an ill-fated US$254 million acquisition of Texas oil assets.